-
Study aim
-
Comparison of the effect of misoprostol alone and misoprostol with estrogen in successful induced abortion
-
Design
-
This three-phase clinical trial, with parallel groups, randomized (using the random allocation rule) is performed on 120 pregnant women.
-
Settings and conduct
-
This randomized clinical trial study is performed on 120 pregnant women, in Yas Hospital. The sampling method is a convenience method.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Mother age more than 18 years, gestational age up to 28 weeks, first gravidity, first cesarean section repeat, body mass index between 25 to 35 kg/m2, hemoglobin level more than 10 gr/dL. Criteria for not entering: Scar in the uterine, leiomyoma in the uterine, blood coagulation disorder, previous attempts to induce abortion in the current pregnancy, a medical disorder that prohibits abortion for example heart failure, allergy to misoprostol or estradiol, cervicitis and vaginitis, polyhydramnios and the patient withdrawal to participate in the study.
-
Intervention groups
-
In women candidates for abortion, misoprostol is prescribed according to FIGO criteria. In addition, in the intervention group, half of a vaginal estrogen ointment is administered, an hour before misoprostol prescription. Then, vaginal estrogen is administered with misoprostol if needed up to a maximum of three doses.
-
Main outcome variables
-
Successful abortion, number of misoprostol doses used, need for curettage or hysterectomy